sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
½ÇĤËðÉ˶¯ÎïÄ£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÑۿƼ²²¡Ä£×Ó > ½ÇĤËðÉ˶¯ÎïÄ£×Ó

ǰÑÔ

½ÇĤËðÉËÆ¾Ö¤ÌõÀíµÄ²î±ð £¬¿É·ÖΪ½ÇĤÄÚÆ¤µÄËðÉ˺ͽÇĤÉÏÆ¤¼°»ùÖÊËðÉË¡£½ÇĤÄÚÆ¤µÄËðÉË¿Éͨ¹ý»úеËðÉË·¨£¨ÕëÍ·´ÌÈëǰ·¿¶ÔÄÚÆ¤¾ÙÐйγýµÈ£©ºÍ´©Í¸ÐÔ½ÇĤÀä¶³·¨µÈ¾ÙÐи´ÖÆ¡£½ÇĤÉÏÆ¤¼°»ùÖÊËðÉËÒ²¿ÉÒÔͨ¹ý»úеËðÉË·¨£¨Çгý¼ÒÍýÇĤ°å²ã¼°½ÇĤԵµÄ½áĤ¼°½ÇĤԵÉÏÆ¤£©»ò¼¤¹âËðÉËÀ´ÊµÏÖ¡£ÒÔÏÂÖ÷ÒªÏÈÈݼ¤¹â½ÇĤËðÉËÄ£×Ó¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎʵÑ鶯Îï

¡¾ÔìÄ£»úÖÆ¡¿£º

ÑÛÊÇ»úÌåÖжԼ¤¹â×îΪÃô¸Ð¡¢×îÒ×ÊÜËðÉËµÄ°ÐÆ÷¹Ù¡£¼¤¹âÖÂÑÛËðÉ˵IJ¿Î»Ö÷ҪΪ½ÇĤ¼°ÑÛµ×ÊÓÍøÄ¤ £¬¼¤¹â²ÎÊýµÄ²î±ð»á¶ÔËðÉ˲¿Î»ºÍˮƽÔì³ÉºÜ´óÓ°Ïì¡£½ÇĤÊÇÑÛÇò×îÇ°ÃæµÄÒ»²ã±¡Ä¤ £¬¶ÔÓÚ²¨ÊÇ·ÇÓÚ280nmµÄÔ¶×ÏÍâÏßÎüÊÕÂÊ¿¿½ü100£¥ £¬¹ØÓÚ1900nmÒÔÉϵÄÖкìÍâºÍÔ¶ºìÍâÏß½ÇĤÊÇÈ«ÎüÊÕÌå¡£Òò¶ø £¬½ÇĤÒ×ÊÜ×ÏÍâ¼°ÖÐÔ¶ºìÍ⼤¹âËðÉË¡£CO2¼¤¹âµÄ²¨³¤Îª10.6?m £¬ÎªÒ»ÖÖÔ¶ºìÍ⼤¹â¡£ÉúÎï×éÖ¯¶ÔCO2¼¤¹âµÄÎüÊÕϵÊýºÜ´ó £¬ÆäÉúÎï×÷ÓûúÖÆÖ÷ÒªÊÇÈÈ×÷Óà £¬µ±µÍÄÜ×îÊä³ö¡¢¶Ìʱ¼äÕÕÉäʱ £¬CO2¼¤¹âÄÜÁ¿µÄ98£¥±»½ÇĤ×î³õµÄ40?mºñ¶ÈËùÎüÊÕ £¬²¢ÇÒÖ÷Òª±»¸»º¬Ë®·ÖµÄÉÏÆ¤Ï¸°ûÎüÊÕ £¬ÒýÆðºÜСµÄÈÈÀ©É¢ £¬Ôì³É½ÇĤËðÉ˼°ñ£ºÛÐγÉ¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

ʵÑ鶯ÎïÂé×íºó £¬Á¬Ã¦ÒÔCO2¼¤¹â±ÊÖ±ÕÕÉä½ÇĤÖÐÑë £¬¹â°ßÖ±¾¶5mm £¬ÌìÌì2´ÎÂÈÃ¹ËØµÎÑÛ £¬ÁÑ϶µÆÏÔ΢¾µÊӲ첢һÁ¬2¸öÔ¡£

¡¾Ä£×ÓÌØµã¡¿£º

½ÇĤËðÉËÇáÕß·ºÆð°×É«»ò»Ò°×É«Äý¹Ì°ß £¬ÕâÖÖËðÉËÊÇ¿ÉÄæµÄ £¬Óúºó²»Áôñ£ºÛ£»ËðÉ˽ÏÖØÕß £¬¿ÉÀÛ¼°½ÇĤ»ùÖÊÉî²ã £¬ÓúºóÁôñ£ºÛ £¬ÕÚµ²Í«¿×ʱӰÏìÊÓÁ¦£»ÖضÈËðÉËÕß¿ÉÔì³É½ÇĤ´©¿× £¬ÒýÆðʧÃ÷¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

¼ÒÍÃʵÑéÑо¿Åú×¢ £¬ÔÚÕÕÉäʱ¼ä1Ãë¡¢¹¦ÂÊÃܶÈ127W/cm2ʱ £¬×îÖÕ60£¥½ÇĤ·ºÆð´©¿× £¬40£¥½ÇĤ·ºÆðñ£ºÛ £¬ñ£ºÛÖ±¾¶6.8mm ×óÓÒ £¬¸ö±ðµÄÓÐѪ¹ÜÔöÉú £¬ñ£ºÛÉî´ï½ÇĤȫ²ã¡£ÕÕÉäʱ¼ä1Ãë £¬¹¦ÂÊÃܶÈ102W/cm2ʱ £¬30ÌìºóËùÓнÇĤ¾ù·ºÆðñ£ºÛ £¬ñ£ºÛÖ±¾¶6.4mm×óÓÒ£»Ïàͬ¹¦ÂÊÃܶÈÕÕÉä0.5Ãëʱ £¬20ÌìºóËùÓзºÆðñ£ºÛ £¬ñ£ºÛÖ±¾¶5.7mm×óÓÒ¡£¹¦ÂÊÃܶÈ62W/cm2 £¬Ê±¼ä0.5Ãë £¬16ÌìºóËùÓзºÆðñ£ºÛ £¬ñ£ºÛÖ±¾¶5.3mm×óÓÒ¡£Òò´Ë £¬ ÒÔΪ½ÇĤñ£ºÛÄ£×ӽϺÏÊʵ魯â²ÎÊýΪÄÜ×îÃܶÈ30~100J/cm2 £¬ñ£ºÛÐγÉʱ¼äΪÕÕºó15~30Ìì¡£ÔÚ½¨Éè½ÇĤËðÉËÄ£×Óʱ £¬¼¤¹âÕÕÉäǰ½ÇĤµÄ̻¶ÇéÐβî±ð»áÔì³É½ÇĤÍâòˮº¬Á¿²î±ð £¬´Ó¶øÓ°Ïì½ÇĤËðÉËˮƽ¡£

?

²Î¿¼ÎÄÏ×£º

1.ÇñÅàèª.?½ÇĤÐÂÉúѪ¹ÜµÄ¶¯ÎïÄ£×Ó£®ÍâÑóҽѧ£ºÑÛ¿ÆÑ§·Ö²á £¬2000, 24 (6):360-363

2.ºú¶«¶« £¬Íõ¼ÎÈÝ £¬ÑîÔÚ¸»£®¼¤¹âÑÛËðÉ˶¯ÎïУÐÍÑо¿Ï£Íû£®¾üÊÂҽѧ¿ÆÑ§ÔºÔº¿¯ £¬2010,5:489-491

3.Äô°®ÇÛ £¬Ï¯Ãç £¬Ï¯ÐË»ª £¬µÈ´¿´â°ÌÕ¶¾ÐÔ½ÇĤÑ×¢òÊóÄ£×ӵĽ¨Éè¼°ÅжϹú¼ÊÑÛ¿ÆÔÓÖ¾ £¬2012,12(11): 2059-2061

4.ÐìÑÒ±äÓ¦ÐÔ½áĤÑ×¶¯ÎïÄ£×ÓÑÛ¿ÆÑо¿ £¬2001, 19(2):181-183

5.κÈ𻪠£¬ºÂÓÀÄÈ £¬ÕÔÉÙÕ꣮×ÔÉíÃâÒßÏà¹ØÐÔ¸ÉÑÛ¶¯ÎïÄ£×ÓµÄÑо¿Ï£Íû£®ÑÛ¿ÆÐÂÏ£Íû £¬2012, 32 (7):690-693

6.Calonge MC, Pastor JC, Herreras JM, el al. Pharmacologic modulation of vascular permeability in ocular allergy in?the rat.?Invest Ophthalmol Vis Sci, 1990, 31 (1): 176-180

7.Marquart ME.Animal models of bacterial keratitis.J Biomed Biotechnol,2011,2011:680642

8.Pavan-Langston D. Herpes simplex virus ocular infections:current concepts of acute, latent and reactivated disease. Trans Am Ophthalmol Soc, 1990,88:727-796

?

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÑۿƼ²²¡Ä£×Ó > ½ÇĤËðÉ˶¯ÎïÄ£×Ó
½ÇĤËðÉ˶¯ÎïÄ£×Ó

ǰÑÔ

½ÇĤËðÉËÆ¾Ö¤ÌõÀíµÄ²î±ð £¬¿É·ÖΪ½ÇĤÄÚÆ¤µÄËðÉ˺ͽÇĤÉÏÆ¤¼°»ùÖÊËðÉË¡£½ÇĤÄÚÆ¤µÄËðÉË¿Éͨ¹ý»úеËðÉË·¨£¨ÕëÍ·´ÌÈëǰ·¿¶ÔÄÚÆ¤¾ÙÐйγýµÈ£©ºÍ´©Í¸ÐÔ½ÇĤÀä¶³·¨µÈ¾ÙÐи´ÖÆ¡£½ÇĤÉÏÆ¤¼°»ùÖÊËðÉËÒ²¿ÉÒÔͨ¹ý»úеËðÉË·¨£¨Çгý¼ÒÍýÇĤ°å²ã¼°½ÇĤԵµÄ½áĤ¼°½ÇĤԵÉÏÆ¤£©»ò¼¤¹âËðÉËÀ´ÊµÏÖ¡£ÒÔÏÂÖ÷ÒªÏÈÈݼ¤¹â½ÇĤËðÉËÄ£×Ó¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎʵÑ鶯Îï

¡¾ÔìÄ£»úÖÆ¡¿£º

ÑÛÊÇ»úÌåÖжԼ¤¹â×îΪÃô¸Ð¡¢×îÒ×ÊÜËðÉËµÄ°ÐÆ÷¹Ù¡£¼¤¹âÖÂÑÛËðÉ˵IJ¿Î»Ö÷ҪΪ½ÇĤ¼°ÑÛµ×ÊÓÍøÄ¤ £¬¼¤¹â²ÎÊýµÄ²î±ð»á¶ÔËðÉ˲¿Î»ºÍˮƽÔì³ÉºÜ´óÓ°Ïì¡£½ÇĤÊÇÑÛÇò×îÇ°ÃæµÄÒ»²ã±¡Ä¤ £¬¶ÔÓÚ²¨ÊÇ·ÇÓÚ280nmµÄÔ¶×ÏÍâÏßÎüÊÕÂÊ¿¿½ü100£¥ £¬¹ØÓÚ1900nmÒÔÉϵÄÖкìÍâºÍÔ¶ºìÍâÏß½ÇĤÊÇÈ«ÎüÊÕÌå¡£Òò¶ø £¬½ÇĤÒ×ÊÜ×ÏÍâ¼°ÖÐÔ¶ºìÍ⼤¹âËðÉË¡£CO2¼¤¹âµÄ²¨³¤Îª10.6?m £¬ÎªÒ»ÖÖÔ¶ºìÍ⼤¹â¡£ÉúÎï×éÖ¯¶ÔCO2¼¤¹âµÄÎüÊÕϵÊýºÜ´ó £¬ÆäÉúÎï×÷ÓûúÖÆÖ÷ÒªÊÇÈÈ×÷Óà £¬µ±µÍÄÜ×îÊä³ö¡¢¶Ìʱ¼äÕÕÉäʱ £¬CO2¼¤¹âÄÜÁ¿µÄ98£¥±»½ÇĤ×î³õµÄ40?mºñ¶ÈËùÎüÊÕ £¬²¢ÇÒÖ÷Òª±»¸»º¬Ë®·ÖµÄÉÏÆ¤Ï¸°ûÎüÊÕ £¬ÒýÆðºÜСµÄÈÈÀ©É¢ £¬Ôì³É½ÇĤËðÉ˼°ñ£ºÛÐγÉ¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

ʵÑ鶯ÎïÂé×íºó £¬Á¬Ã¦ÒÔCO2¼¤¹â±ÊÖ±ÕÕÉä½ÇĤÖÐÑë £¬¹â°ßÖ±¾¶5mm £¬ÌìÌì2´ÎÂÈÃ¹ËØµÎÑÛ £¬ÁÑ϶µÆÏÔ΢¾µÊӲ첢һÁ¬2¸öÔ¡£

¡¾Ä£×ÓÌØµã¡¿£º

½ÇĤËðÉËÇáÕß·ºÆð°×É«»ò»Ò°×É«Äý¹Ì°ß £¬ÕâÖÖËðÉËÊÇ¿ÉÄæµÄ £¬Óúºó²»Áôñ£ºÛ£»ËðÉ˽ÏÖØÕß £¬¿ÉÀÛ¼°½ÇĤ»ùÖÊÉî²ã £¬ÓúºóÁôñ£ºÛ £¬ÕÚµ²Í«¿×ʱӰÏìÊÓÁ¦£»ÖضÈËðÉËÕß¿ÉÔì³É½ÇĤ´©¿× £¬ÒýÆðʧÃ÷¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

¼ÒÍÃʵÑéÑо¿Åú×¢ £¬ÔÚÕÕÉäʱ¼ä1Ãë¡¢¹¦ÂÊÃܶÈ127W/cm2ʱ £¬×îÖÕ60£¥½ÇĤ·ºÆð´©¿× £¬40£¥½ÇĤ·ºÆðñ£ºÛ £¬ñ£ºÛÖ±¾¶6.8mm ×óÓÒ £¬¸ö±ðµÄÓÐѪ¹ÜÔöÉú £¬ñ£ºÛÉî´ï½ÇĤȫ²ã¡£ÕÕÉäʱ¼ä1Ãë £¬¹¦ÂÊÃܶÈ102W/cm2ʱ £¬30ÌìºóËùÓнÇĤ¾ù·ºÆðñ£ºÛ £¬ñ£ºÛÖ±¾¶6.4mm×óÓÒ£»Ïàͬ¹¦ÂÊÃܶÈÕÕÉä0.5Ãëʱ £¬20ÌìºóËùÓзºÆðñ£ºÛ £¬ñ£ºÛÖ±¾¶5.7mm×óÓÒ¡£¹¦ÂÊÃܶÈ62W/cm2 £¬Ê±¼ä0.5Ãë £¬16ÌìºóËùÓзºÆðñ£ºÛ £¬ñ£ºÛÖ±¾¶5.3mm×óÓÒ¡£Òò´Ë £¬ ÒÔΪ½ÇĤñ£ºÛÄ£×ӽϺÏÊʵ魯â²ÎÊýΪÄÜ×îÃܶÈ30~100J/cm2 £¬ñ£ºÛÐγÉʱ¼äΪÕÕºó15~30Ìì¡£ÔÚ½¨Éè½ÇĤËðÉËÄ£×Óʱ £¬¼¤¹âÕÕÉäǰ½ÇĤµÄ̻¶ÇéÐβî±ð»áÔì³É½ÇĤÍâòˮº¬Á¿²î±ð £¬´Ó¶øÓ°Ïì½ÇĤËðÉËˮƽ¡£

?

²Î¿¼ÎÄÏ×£º

1.ÇñÅàèª.?½ÇĤÐÂÉúѪ¹ÜµÄ¶¯ÎïÄ£×Ó£®ÍâÑóҽѧ£ºÑÛ¿ÆÑ§·Ö²á £¬2000, 24 (6):360-363

2.ºú¶«¶« £¬Íõ¼ÎÈÝ £¬ÑîÔÚ¸»£®¼¤¹âÑÛËðÉ˶¯ÎïУÐÍÑо¿Ï£Íû£®¾üÊÂҽѧ¿ÆÑ§ÔºÔº¿¯ £¬2010,5:489-491

3.Äô°®ÇÛ £¬Ï¯Ãç £¬Ï¯ÐË»ª £¬µÈ´¿´â°ÌÕ¶¾ÐÔ½ÇĤÑ×¢òÊóÄ£×ӵĽ¨Éè¼°ÅжϹú¼ÊÑÛ¿ÆÔÓÖ¾ £¬2012,12(11): 2059-2061

4.ÐìÑÒ±äÓ¦ÐÔ½áĤÑ×¶¯ÎïÄ£×ÓÑÛ¿ÆÑо¿ £¬2001, 19(2):181-183

5.κÈ𻪠£¬ºÂÓÀÄÈ £¬ÕÔÉÙÕ꣮×ÔÉíÃâÒßÏà¹ØÐÔ¸ÉÑÛ¶¯ÎïÄ£×ÓµÄÑо¿Ï£Íû£®ÑÛ¿ÆÐÂÏ£Íû £¬2012, 32 (7):690-693

6.Calonge MC, Pastor JC, Herreras JM, el al. Pharmacologic modulation of vascular permeability in ocular allergy in?the rat.?Invest Ophthalmol Vis Sci, 1990, 31 (1): 176-180

7.Marquart ME.Animal models of bacterial keratitis.J Biomed Biotechnol,2011,2011:680642

8.Pavan-Langston D. Herpes simplex virus ocular infections:current concepts of acute, latent and reactivated disease. Trans Am Ophthalmol Soc, 1990,88:727-796

?

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿